Finerenone in the management of Diabetic Kidney Disease: A consensus statement by the Association of British Clinical Diabetologists and UK Kidney Association

This consensus statement by the Association of British Clinical Diabetologists and UK Kidney Association provides context and recommendations regarding the use Finerenone in the management of Diabetic Kidney Disease.

Discipline

Diabetes Endocrinology
Resource taxonomy
Position Paper
Clinical taxonomy
Chronic kidney disease Type 2 diabetes mellitus
Listing status
Current

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Eli Lilly and Company
  • Sanofi

Silver

  • A Menarini Farmaceutica Internazionale SRL

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • GlucoRx Ltd
  • Insulet International
  • Ypsomed Ltd

Silver

  • A. Menarini Diagnostics
  • Air Liquide Healthcare Ltd
  • Medtronic Limited
  • Medtrum Ltd

Bronze

  • Roche Diabetes Care

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE  Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE . ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd